Garrido-Laguna I - Search Results

1

Therapeutic Targeting of Autophagy in Pancreatic Cancer.

Foth M, Garrido-Laguna I, Kinsey CG. Foth M, et al. Surg Oncol Clin N Am. 2021 Oct;30(4):709-718. doi: 10.1016/j.soc.2021.06.001. Epub 2021 Jul 22. Surg Oncol Clin N Am. 2021. PMID: 34511191 Review.

2

Pancreatic cancer: from state-of-the-art treatments to promising novel therapies.

Garrido-Laguna I, Hidalgo M. Garrido-Laguna I, et al. Nat Rev Clin Oncol. 2015 Jun;12(6):319-34. doi: 10.1038/nrclinonc.2015.53. Epub 2015 Mar 31. Nat Rev Clin Oncol. 2015. PMID: 25824606 Review.

3

Multiagent induction chemotherapy followed by chemoradiation is associated with improved survival in locally advanced pancreatic cancer.

Torgeson A, Lloyd S, Boothe D, Tao R, Whisenant J, Garrido-Laguna I, Cannon GM. Torgeson A, et al. Cancer. 2017 Oct 1;123(19):3816-3824. doi: 10.1002/cncr.30780. Epub 2017 Jun 16. Cancer. 2017. PMID: 28621885 Free article.

4

Metastatic Pancreatic Cancer: ASCO Clinical Practice Guideline Update.

Sohal DPS, Kennedy EB, Khorana A, Copur MS, Crane CH, Garrido-Laguna I, Krishnamurthi S, Moravek C, O'Reilly EM, Philip PA, Ramanathan RK, Ruggiero JT, Shah MA, Urba S, Uronis HE, Lau MW, Laheru D. Sohal DPS, et al. J Clin Oncol. 2018 Aug 20;36(24):2545-2556. doi: 10.1200/JCO.2018.78.9636. Epub 2018 May 23. J Clin Oncol. 2018. PMID: 29791286 Free PMC article.

5

Combination immunotherapy and radiation therapy strategies for pancreatic cancer-targeting multiple steps in the cancer immunity cycle.

Gajiwala S, Torgeson A, Garrido-Laguna I, Kinsey C, Lloyd S. Gajiwala S, et al. J Gastrointest Oncol. 2018 Dec;9(6):1014-1026. doi: 10.21037/jgo.2018.05.16. J Gastrointest Oncol. 2018. PMID: 30603120 Free PMC article. Review.

6

From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer.

Nevala-Plagemann C, Hidalgo M, Garrido-Laguna I. Nevala-Plagemann C, et al. Nat Rev Clin Oncol. 2020 Feb;17(2):108-123. doi: 10.1038/s41571-019-0281-6. Epub 2019 Nov 8. Nat Rev Clin Oncol. 2020. PMID: 31705130 Review.

7

The impact of squamous cell carcinoma histology on outcomes in nonmetastatic pancreatic cancer.

Gruhl JD, Garrido-Laguna I, Francis SR, Affolter K, Tao R, Lloyd S. Gruhl JD, et al. Cancer Med. 2020 Mar;9(5):1703-1711. doi: 10.1002/cam4.2851. Epub 2020 Jan 16. Cancer Med. 2020. PMID: 31945808 Free PMC article.

8

Inhibition of MEK1/2 Forestalls the Onset of Acquired Resistance to Entrectinib in Multiple Models of NTRK1-Driven Cancer.

Vaishnavi A, Scherzer MT, Kinsey CG, Parkman GL, Truong A, Ghazi P, Schuman S, Battistone B, Garrido-Laguna I, McMahon M. Vaishnavi A, et al. Cell Rep. 2020 Aug 4;32(5):107994. doi: 10.1016/j.celrep.2020.107994. Cell Rep. 2020. PMID: 32755586 Free PMC article.

9

Emerging Treatment Strategies in Pancreatic Cancer.

Trunk A, Miotke L, Nevala-Plagemann C, Verdaguer H, Macarulla T, Garrido-Laguna I. Trunk A, et al. Pancreas. 2021 Jul 1;50(6):773-787. doi: 10.1097/MPA.0000000000001845. Pancreas. 2021. PMID: 34398070 Review.

10

Clinical Development of Anti-TIGIT Antibodies for Immunotherapy of Cancer.

Florou V, Garrido-Laguna I. Florou V, et al. Curr Oncol Rep. 2022 Sep;24(9):1107-1112. doi: 10.1007/s11912-022-01281-5. Epub 2022 Apr 12. Curr Oncol Rep. 2022. PMID: 35412226 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

111 results

Search Page